Dr. Keith Heinzerling is the Chief Scientific and Medical Officer for TRIP Clinics, leveraging over 20 years of experience in clinical trials for mental health and addiction. A Stanford Medical School alumnus and former UCLA faculty, he is a nationally recognized expert in addiction medicine, psychedelics, and developing new cannabinoid-based medications through his startup, BDH Pharma.
Outside of his clinical work, Keith is a self-described "student of spiritual science, " aiming to merge science and spirituality to advance human consciousness. He co-founded ReWild Medicine to explore how psychedelics can deepen our connection to nature and SkyFire Retreats to host gatherings for profound spiritual growth. He also enjoys hiking, skiing, and backpacking.
He is a pioneer in researching and offering psychedelic-assisted psychotherapy, leading clinical trials with psilocybin and LSD for addiction and mental health disorders.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.